Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12 440 patients of the ESC Heart Failure Long‐Term Registry
Top Cited Papers
Open Access
- 1 October 2013
- journal article
- research article
- Published by Wiley in European Journal of Heart Failure
- Vol. 15 (10), 1173-1184
- https://doi.org/10.1093/eurjhf/hft134
Abstract
Aims To evaluate how recommendations of European guidelines regarding pharmacological and non-pharmacological treatments for heart failure (HF) are adopted in clinical practice. Methods and results The ESC-HF Long-Term Registry is a prospective, observational study conducted in 211 Cardiology Centres of 21 European and Mediterranean countries, members of the European Society of Cardiology (ESC). From May 2011 to April 2013, a total of 12 440 patients were enrolled, 40.5% with acute HF and 59.5% with chronic HF. Intravenous treatments for acute HF were heterogeneously administered, irrespective of guideline recommendations. In chronic HF, with reduced EF, renin–angiotensin system (RAS) blockers, beta-blockers, and mineralocorticoid antagonists (MRAs) were used in 92.2, 92.7, and 67.0% of patients, respectively. When reasons for non-adherence were considered, the real rate of undertreatment accounted for 3.2, 2.3, and 5.4% of the cases, respectively. About 30% of patients received the target dosage of these drugs, but a documented reason for not achieving the target dosage was reported in almost two-thirds of them. The more relevant reasons for non-implantation of a device, when clinically indicated, were related to doctor uncertainties on the indication, patient refusal, or logistical/cost issues. Conclusion This pan-European registry shows that, while in patients with acute HF, a large heterogeneity of treatments exists, drug treatment of chronic HF can be considered largely adherent to recommendations of current guidelines, when the reasons for non-adherence are taken into account. Observations regarding the real possibility to adhere fully to current guidelines in daily clinical practice should be seriously considered when clinical practice guidelines have to be written.Keywords
This publication has 28 references indexed in Scilit:
- Multicenter Prospective Observational Study on Acute and Chronic Heart FailureCirculation: Heart Failure, 2013
- Hospital Patterns of Use of Positive Inotropic Agents in Patients With Heart FailureJournal of the American College of Cardiology, 2012
- ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012European Journal of Heart Failure, 2012
- Titration to target dose of bisoprolol vs. carvedilol in elderly patients with heart failure: the CIBIS-ELD trialEuropean Journal of Heart Failure, 2011
- HFSA 2010 Comprehensive Heart Failure Practice GuidelineJournal of Cardiac Failure, 2010
- The European cardiac resynchronization therapy surveyEuropean Heart Journal, 2009
- Long-Term Trends in First Hospitalization for Heart Failure and Subsequent Survival Between 1986 and 2003Circulation, 2009
- Clinical epidemiology of heart failureHeart, 2007
- Characteristics and outcomes of patients hospitalized for heart failure in the United States: Rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE)American Heart Journal, 2005
- The underutilization of cardiacmedications of proven benefit, 1990 to 2002Journal of the American College of Cardiology, 2003